Re: Tumour progression or pseudoprogression? A review of post-treatment radiological appearances of glioblastoma
Thomas C. Booth(King's College London), Adam Waldman(Royal Society of Edinburgh), Hans Rolf Jäger(National Hospital for Neurology and Neurosurgery), L. Brazil(King's College Hospital NHS Foundation Trust), K. Ashkan(King's College Hospital NHS Foundation Trust)
Cited by 6
Related Papers
Evaluation of Patients Treated with Natalizumab for Progressive Multifocal Leukoencephalopathy
|New England Journal of Medicine|2006|792
Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial
|The Lancet Neurology|2008|774
The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy study
|The Lancet Neurology|2022|651
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas
|The Lancet Oncology|2011|649
Imaging biomarkers of vulnerable carotid plaques for stroke risk prediction and their potential clinical implications
|The Lancet Neurology|2019|500